share_log

Doximity | 10-Q: Q2 2025 Earnings Report

Doximity | 10-Q: Q2 2025 Earnings Report

Doximity | 10-Q：2025财年二季报
美股SEC公告 ·  2024/11/07 22:35

Moomoo AI 已提取核心信息

Doximity reported strong financial results for Q2 FY2025 ended September 30, 2024, with revenue increasing 20% year-over-year to $136.8 million. Net income rose 44% to $44.2 million, while adjusted EBITDA grew 41% to $76.1 million with a 56% margin. The company maintained its industry-leading net revenue retention rate of 116%.The company's core business showed robust growth, with subscription revenue up significantly driven by both new customer acquisition and existing customer expansion. Marketing Solutions customers increased average revenue by 22% YoY through new brands and service lines. The number of customers contributing over $500,000 in trailing 12-month revenue grew to 103, accounting for 83% of total revenue.Looking ahead, Doximity continues to strengthen its position as the leading digital platform for U.S. medical professionals, with over 80% physician membership across all 50 states. The company executed a sublease for its Texas office space resulting in a $2.3 million impairment charge, while maintaining strong cash position with $805.6 million in cash and marketable securities. A new $500 million share repurchase program was authorized in May 2024.
Doximity reported strong financial results for Q2 FY2025 ended September 30, 2024, with revenue increasing 20% year-over-year to $136.8 million. Net income rose 44% to $44.2 million, while adjusted EBITDA grew 41% to $76.1 million with a 56% margin. The company maintained its industry-leading net revenue retention rate of 116%.The company's core business showed robust growth, with subscription revenue up significantly driven by both new customer acquisition and existing customer expansion. Marketing Solutions customers increased average revenue by 22% YoY through new brands and service lines. The number of customers contributing over $500,000 in trailing 12-month revenue grew to 103, accounting for 83% of total revenue.Looking ahead, Doximity continues to strengthen its position as the leading digital platform for U.S. medical professionals, with over 80% physician membership across all 50 states. The company executed a sublease for its Texas office space resulting in a $2.3 million impairment charge, while maintaining strong cash position with $805.6 million in cash and marketable securities. A new $500 million share repurchase program was authorized in May 2024.
Doximity报告了截至2024年9月30日的2025财年第二季度强劲财务业绩，营业收入同比增长20%，达到13680万美元。净利润增长44%，达到4420万美元，而调整后的EBITDA增长41%，达到7610万美元，净利润率为56%。该公司保持了116%的行业领先净营业收入留存率。公司的核心业务表现出强劲增长，订阅收入大幅上升，主要受新客户获取和现有客户扩展的驱动。营销解决方案客户的平均收入同比增长22%，通过新品牌和服务线实现增长。贡献超过50万美元的客户数量增长至103，占总营业收入的83%。展望未来，Doximity继续巩固其作为美国医疗专业人士领先数字平台的地位，医生会员覆盖所有50个州超过80%。该公司为其德克萨斯州的办公空间签订了子租赁，导致230万美元的减值费用，同时保持强劲的现金状况，现金和可交易证券总额为80560万美元。2024年5月授权了一项新的50000万美元的股票回购计划。
Doximity报告了截至2024年9月30日的2025财年第二季度强劲财务业绩，营业收入同比增长20%，达到13680万美元。净利润增长44%，达到4420万美元，而调整后的EBITDA增长41%，达到7610万美元，净利润率为56%。该公司保持了116%的行业领先净营业收入留存率。公司的核心业务表现出强劲增长，订阅收入大幅上升，主要受新客户获取和现有客户扩展的驱动。营销解决方案客户的平均收入同比增长22%，通过新品牌和服务线实现增长。贡献超过50万美元的客户数量增长至103，占总营业收入的83%。展望未来，Doximity继续巩固其作为美国医疗专业人士领先数字平台的地位，医生会员覆盖所有50个州超过80%。该公司为其德克萨斯州的办公空间签订了子租赁，导致230万美元的减值费用，同时保持强劲的现金状况，现金和可交易证券总额为80560万美元。2024年5月授权了一项新的50000万美元的股票回购计划。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Forian
    FORA
    -- 3.590
    Ontrak
    OTRK
    -- 1.5900
    Mangoceuticals
    MGRX
    -- 4.840
    DarioHealth
    DRIO
    -- 0.700
    VSee Health
    VSEE
    -- 1.870
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    特斯拉绩后巨震，后市你怎么看？
    特斯拉2024年Q4营收257.1亿美元，同比增长2%，不及预期。Cybercab计划2026年投产，预计车辆业务将于2025年恢复增长。面对特朗普回归，特斯拉股价能否在2025年继续攀升？ 展开
    TSLA财报预告：通过猜测开盘价来获取奖励！